Al Minjock - Making the Case for Making Cents (Sense): Improving Economic Outcomes 2010

1.	Making the case for making cents (sense): Improving Economic Outcomes
2.	The Leapfrog Group
3.	The Burden of Severe Sepsis
4.	Sepsis Encounters
5.	Sepsis Encounters cont.
6.	Sepsis: Leading cause of death in non-coronary ICUs
7.	Sepsis is Costly
8.	Sepsis Costs
9.	What is Early Goal Directed Therapy?
10.	EGDT Saves Lives
11.	EGDT Body of Evidence
12.	EGDT is Cost-Effective
13.	EGDT Comparisons
14.	The Joint Commission Recognizes the Value of EGDT
15.	Potential Impact of EGDT - Example
16.	Potential Impact of EGDT - Example cont.

17.	Shoemaker et al. Chest 1988
18.	Boyd et al. JAMA 1993
19.	Wilson et al. BMJ 1999
20.	Wilson et al. BMJ 1999 cont.
21.	Wilson et al. BMJ 1999 cont.
22.	Introduction
23.	TPS as an Operational Weapon
24.	The 4 P P’s
25.	4-Tier Process for Process Program Implementation
26.	The Concept
27.	14 Principles of TPS/Lean
28.	14 Principles of TPS/Lean cont.
29.	14 Principles of TPS/Lean cont.
30.	Receiver-Operator Characteristic (ROC) Curve
31.	“Leaks Leaks” from Research to Practice
32.	Improving Economic Outcomes: What makes cents (sense)

Download slide show of this PowerPoint Presentation for off-line usage.

Al Minjock is an employee of Edwards Lifesciences. Any quotes used in this material are taken from independent third-party publications and are not intended to imply that such third party received or endorsed any of the products of Edwards Lifesciences.

Early Goal-Directed Therapy and EGDT are trademarks of Dr. Emanuel Rivers.

CAUTION: Federal (United States) law restricts this device to sale by or on the order of a physician. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions and adverse events.